We hypothesized that tumors that express CD74 along with MHCII, both key components of the antigen presenting machinery, represent those tumors most susceptible to a productive tumor infiltrating leukocyte (TIL) response and correspondingly good outcomes. This evidence concerns the gene CD74 and neoplasm.